EXPERIENCE OF USING THE DRUG SELEXIPAG IN THE TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

被引：1
作者：
Karelkina, E. V. [1 ]
Goncharova, N. S. [1 ]
Simakova, M. A. [1 ]
Moiseeva, O. M. [1 ]
机构：
[1] FGBU Natl Med Res Ctr, St Petersburg, Russia
来源：
KARDIOLOGIYA | 2020年 / 60卷 / 04期
关键词：
PROSTACYCLIN-RECEPTOR AGONIST;
D O I：
10.18087/cardio.2020.4.n1026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：36 / 42
页数：6
相关论文
共 42 条
  • [21] Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension
    Tanabe, Nobuhiro
    Ikeda, Satoshi
    Tahara, Nobuhiro
    Fukuda, Keiichi
    Hatano, Masaru
    Ito, Hiroshi
    Nakayama, Tomotaka
    Anzai, Toshihisa
    Hashimoto, Akiyoshi
    Inoue, Teruo
    Kajinami, Kouji
    Kihara, Yasuki
    Kinoshita, Hideyuki
    Kuwahara, Koichiro
    Murohara, Toyoaki
    Okazaki, Osamu
    Sakai, Satoshi
    Satoh, Toru
    Takeda, Yutaka
    Takeishi, Yasuchika
    Taniguchi, Mitsugu
    Watanabe, Hiroshi
    Yamamoto, Takeshi
    Yamauchi-Takihara, Keiko
    Yoshioka, Koichiro
    Sasayama, Shigetake
    CIRCULATION JOURNAL, 2017, 81 (09) : 1360 - 1367
  • [22] Clinical efficacy and safety of selexipag in children and young adults with idiopathic and heritable pulmonary arterial hypertension
    Takatsuki, Shinichi
    Nakayama, Tomotaka
    Shimizu, Yurika
    Kawai, Reiko
    Matsuura, Hiroyuki
    CARDIOLOGY IN THE YOUNG, 2023, 33 (02) : 196 - 200
  • [23] Selexipag in Pulmonary Arterial Hypertension: Most Updated Evidence From Recent Preclinical and Clinical Studies
    Ghosh, Raktim K.
    Ball, Somedeb
    Das, Avash
    Bandyopadhyay, Dhrubajyoti
    Mondal, Samhati
    Saha, Debjit
    Gupta, Anjan
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (05) : 547 - 557
  • [24] Antiproliferative effect of selexipag active metabolite MRE-269 on pulmonary arterial smooth muscle cells from patients with chronic thromboembolic pulmonary hypertension
    Kuramoto, Kazuya
    Ogawa, Aiko
    Kiyama, Kazuko
    Matsubara, Hiromi
    Ohno, Yuji
    Fuchikami, Chiaki
    Hayashi, Kyota
    Kosugi, Keiji
    Kuwano, Keiichi
    PULMONARY CIRCULATION, 2023, 13 (02)
  • [25] Drug Treatment of Pulmonary Hypertension in Children
    Vorhies, Erika E.
    Ivy, David Dunbar
    PEDIATRIC DRUGS, 2014, 16 (01) : 43 - 65
  • [26] Drug Treatment of Pulmonary Hypertension in Children
    Avitabile, Catherine M.
    Vorhies, Erika E.
    Ivy, David Dunbar
    PEDIATRIC DRUGS, 2020, 22 (02) : 123 - 147
  • [27] Selexipag in Patients With Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Qin, Jinlv
    Wang, Guizuo
    Han, Dong
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (02)
  • [28] Pulmonary arterial hypertension
    Montani, David
    Guenther, Sven
    Dorfmueller, Peter
    Perros, Frederic
    Girerd, Barbara
    Garcia, Gilles
    Jais, Xavier
    Savale, Laurent
    Artaud-Macari, Elise
    Price, Laura C.
    Humbert, Marc
    Simonneau, Gerald
    Sitbon, Olivier
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [29] Should we use the oral selective IP receptor agonist selexipag off-label in children with pulmonary arterial hypertension?
    Koestenberger, Martin
    Hansmann, Georg
    PULMONARY CIRCULATION, 2018, 8 (03)
  • [30] A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension
    Mubarak, Kamal K.
    RESPIRATORY MEDICINE, 2010, 104 (01) : 9 - 21
12345